Nerve Growth Factor: A Potential Therapeutic Target for Lung Diseases

被引:28
作者
Liu, Piaoyang [1 ]
Li, Shun [2 ,3 ]
Tang, Liling [1 ]
机构
[1] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China
[2] Chengdu Med Coll, Sch Basic Med Sci, Dept Immunol, Chengdu 610500, Peoples R China
[3] Chengdu Med Coll, Noncoding RNA & Drug Discovery Key Lab Sichuan P, Chengdu 610500, Peoples R China
基金
中国国家自然科学基金;
关键词
nerve growth factor; lung; coronavirus disease 2019; pathway; OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; SMOOTH-MUSCLE; FACTOR NGF; AIRWAY HYPERRESPONSIVENESS; ALLERGIC INFLAMMATION; SYSTEMIC INFLAMMATION; MOUSE MODEL; EXPRESSION; NEUROTROPHINS;
D O I
10.3390/ijms22179112
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The lungs play a very important role in the human respiratory system. However, many factors can destroy the structure of the lung, causing several lung diseases and, often, serious damage to people's health. Nerve growth factor (NGF) is a polypeptide which is widely expressed in lung tissues. Under different microenvironments, NGF participates in the occurrence and development of lung diseases by changing protein expression levels and mediating cell function. In this review, we summarize the functions of NGF as well as some potential underlying mechanisms in pulmonary fibrosis (PF), coronavirus disease 2019 (COVID-19), pulmonary hypertension (PH), asthma, chronic obstructive pulmonary disease (COPD), and lung cancer. Furthermore, we highlight that anti-NGF may be used in future therapeutic strategies.
引用
收藏
页数:12
相关论文
共 106 条
  • [1] Acceleration of TAA-Induced Liver Fibrosis by Stress Exposure Is Associated with Upregulation of Nerve Growth Factor and Glycopattern Deviations
    Atorrasagasti, Catalina
    Piccioni, Flavia
    Borowski, Sophia
    Tirado-Gonzalez, Irene
    Freitag, Nancy
    Cantero, Maria Jose
    Bayo, Juan
    Mazzolini, Guillermo
    Alaniz, Laura D.
    Blois, Sandra M.
    Garcia, Mariana G.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [2] Novel aspects of pathogenesis and regeneration mechanisms in COPD
    Bagdonas, Edvardas
    Raudoniute, Jovile
    Bruzauskaite, Ieva
    Aldonyte, Ruta
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 995 - 1013
  • [3] Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
    Barnes, Peter J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (01) : 16 - 27
  • [4] VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
    Barratt, Shaney L.
    Flower, Victoria A.
    Pauling, John D.
    Millar, Ann B.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [5] Neurotrophins in Asthma
    Barrios, Juliana
    Ai, Xingbin
    [J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2018, 18 (02)
  • [6] Bradshaw Ralph A., 2015, Advances in Biological Regulation, V58, P16, DOI 10.1016/j.jbior.2014.11.003
  • [7] The expression and role of nerve growth factor (NGF) in pulmonary hypertension
    Cardouat, G.
    Guibert, C.
    Freund-Michel, V
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2020, 37 (03) : 205 - 209
  • [8] Clinical and Economic Burden of Elevated Blood Eosinophils in Patients With and Without Uncontrolled Asthma
    Casciano, Julian
    Krishnan, Jerry
    Dotiwala, Zenobia
    Li, Chenghui
    Sun, Shawn X.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (01) : 85 - 91
  • [9] Asthma Exacerbations: Pathogenesis, Prevention, and Treatment
    Castillo, Jamee R.
    Peters, Stephen P.
    Busse, William W.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (04) : 918 - 927
  • [10] High Glucose Enhances Responsiveness of Human Airways Smooth Muscle via the Rho/ROCK Pathway
    Cazzola, Mario
    Calzetta, Luigino
    Rogliani, Paola
    lauro, DaviDe
    Novelli, Lucia
    Page, Clive P.
    Kanabar, Varsha
    Matera, Maria Gabriella
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2012, 47 (04) : 509 - 516